Eur Rev Med Pharmacol Sci 2023; 27 (13): 6101-6110
DOI: 10.26355/eurrev_202307_32966

The progress and controversies regarding steroid use in acute spinal cord injury

W.-T. Chen, Y.-P. Zhou, G.-S. Zhang

Department of Emergency Medicine, The First People’s Hospital of Linhai, Taizhou, Zhejiang, China. genshengzhang@zju.edu.cn


Acute spinal cord injury (SCI) is a devastating disease that causes immense physical and mental harm to the patient and the family, and society and requires a multidisciplinary approach to treatment. The study of acute SCI has a long history but is still emerging. As the mechanism and pathophysiology of acute SCI are continuously being studied and explored, the treatment of SCI has developed significantly. Steroids are thought to provide neuroprotection in patients with acute SCI by improving perfusion, reducing edema, modulating inflammatory cells, and inhibiting lipid peroxidation, leading to their widespread application in clinical medicine. The use of steroids for SCI is controversial because of limited clinical evidence. With the accumulation of evidence on the effectiveness of steroid treatment in improving neurological function and the evidence of severe side effects, a gradual change in the treatment of SCI with steroids has become inevitable. Most scholars have focused on the routine use of steroids because of the indefinite improvement in neurological function and the occurrence of severe adverse events. Therefore, this review aims to provide an overview of the mechanism, progress, and related controversies to comprehensively understand the value and future direction of steroid application in acute SCI.

Free PDF Download

To cite this article

W.-T. Chen, Y.-P. Zhou, G.-S. Zhang
The progress and controversies regarding steroid use in acute spinal cord injury

Eur Rev Med Pharmacol Sci
Year: 2023
Vol. 27 - N. 13
Pages: 6101-6110
DOI: 10.26355/eurrev_202307_32966